http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2241443-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
| filingDate | 2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad839451a66ba207eeec64c88897503c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a46656f891362aa037ab684637a746 |
| publicationDate | 2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2241443-C1 |
| titleOfInvention | Pharmaceutical composition for treatment of herpes viral infection |
| abstract | FIELD: medicine, virology, pharmacy. n SUBSTANCE: invention relates to a pharmaceutical composition used for treatment of herpes viral infection. As an anti-herpetic agent the composition uses the composition comprising glycyrrhizic acid, eftiderm, mefenamic acid, proteolytic enzymes, vehicle as vaselin and lanolin and ethyl alcohol and purified water also taken in the definite ratio. Invention provides the complete arresting the infectious process at stage of latent diseases symptoms, reduces period for treatment of disease up to 1-2 days and prolongs the remission period up to one year and above. n EFFECT: enhanced and valuable medicinal properties of composition. n 3 cl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2486915-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2504397-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2535053-C2 |
| priorityDate | 2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.